Red Cell Genotyping (PA2023)
Key Details
Estimated Value
Not disclosed
Deadline
Not specified
Contract Period
Not specified
Procurement Method
open
CPV Code
33100000 - Medical equipments
Free SME-fit check
Is this tender for me?
Deterministic score from the published notice — not an AI prediction.
30
out of 100
Challenging for many SMEs
On the published fields alone this looks harder for a typical SME (value, time, or missing SME flag). Exceptions exist — check the notice.
Deterministic score from the published notice only (SME/VCSE flags, value, lots, deadline window, framework). Not a prediction you will win, and not legal or bid advice.
Try another notice on the free SME-fit checker.
Key requirements
Extracted from the notice; check the official documents.
- Procedure
- Competitive flexible procedure
- Legal basis
- Procurement Act 2023
- Type
- Framework agreement
- CPV code
- 33100000 Medical equipments
Description
NHS Blood & Transplant (NHSBT) and Scottish National Blood Transfusion (SNBTS) Red Cell Immunohaematology (RCI) departments are awarding a supplier of red cell genotyping methods. The RCI laboratories in NHSBT and SNBTS provide a range of reference services to hospitals, focusing on ensuring safe and effective blood transfusions by diagnosing and managing complex issues related to red blood cells. For some patients, the red cell phenotype cannot be determined due to prior transfusion, treatment with therapeutic monoclonal antibodies, or autoimmune conditions. For these patients, the selection of safe compatible blood for transfusion relies on red cell genotyping, a molecular method of determining blood groups. Blood is often required urgently with increased risk to the patient if this is not met. RCI reference services in NHSBT are provided from Barnsley, Birmingham, Colindale, Filton (Bristol), Liverpool, Newcastle, and Tooting. RCI reference services in SNBTS are provided from Aberdeen, Dundee, Edinburgh, Glasgow and Inverness, although red cell genotyping is only performed on the Glasgow site. NHSBT and SNBTS have now completed a tender and shall award based on the following: • Extended red cell genotype (blood groups). • Weak and Partial Rh D. • Either closed or open system. • Processing batches, but also capable of processing smaller numbers with minimum wastage. • Less than 24-hour TAT, including DNA extraction to results. • Quality requirements (such as CE marked) The framework shall be utilised by NHS Blood and Transplant, Welsh Blood Service,, Scottish National Blood Transfusion Service and the Northern Ireland
Who won
£1.6m · Awarded 22 Jan 2026 · Contract ends 31 Jan 2033 · Award notice ↗
From award notices on Find a Tender and Contracts Finder. SME or Large is the size the supplier declared on the notice (or, where it is silent, on its latest notice). Values are as published.